All In Biotech

Drug Trial Radar · NCT05266430

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

A Prospective Group-Matched Study of Visual Outcomes in Subjects Treated With Belzupacap Sarotalocan (AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

Last checked: Nov 19, 2026Latest source record: Aug 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

2

Actual

Start

Apr 14, 2022

Primary completion

Feb 1, 2023

Study completion Apr 20, 2023

Sponsor

Lead sponsor
Aura BiosciencesIndustry
Sponsor type
Industry
First posted
Mar 4, 2022

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective multicenter, group-matched study of patients with primary indeterminate lesions or choroidal melanoma who receive treatment with belzupacap sarotalocan (bel-sar; AU-011) and patients who are planned to receive standard of care (SOC) treatment with plaque radiotherapy (plaque) to compare the visual outcomes of AU-011 and plaque radiotherapy.

Conditions

  • Choroidal Melanoma
  • Indeterminate Lesions

Interventions

  • Standard of CareOther

    Patients who are planned to receive plaque radiotherapy for the treatment of IL/CM based on the expert judgment of the investigator

  • AU-011Drug

    Previously received

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual AcuityTime frame: 5 years

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Associated Retinal Consultants, P.C.

    Royal Oak, Michigan

  • Oregon Health & Science University Casey Eye Institute

    Portland, Oregon

  • Retina Consultants of Carolina, PA

    Greenville, South Carolina

  • St. Thomas Health/Tennessee Retina, P.C.

    Nashville, Tennessee

  • Retina Consultants of Texas

    Bellaire, Texas

  • Texas Retina Associates

    Dallas, Texas

  • University of Wisconsin Dept of Ophthalmology & Visual Sciences

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.